Chronic inflammatory demyelinating polyneuropathy as a paraneoplastic manifestation of colorectal carcinoma: What do we know?
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Medicine and Surgery"
DOI: 10.1016/j.amsu.2021.102545
Abstract: The pathogenesis of chronic inflammatory demyelinating polyneuropathy (CIDP) remains highly debated among experts. In recent times, literature has divulged a riveting yet plausible association between colorectal carcinoma and CIDP as its paraneoplastic ramification. Initially, research… read more here.
Keywords: inflammatory demyelinating; demyelination; demyelinating polyneuropathy; colorectal carcinoma ... See more keywords
P85-T Diagnostic value of conduction block in demyelinating polyneuropathies
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Neurophysiology"
DOI: 10.1016/j.clinph.2019.04.446
Abstract: Background Conduction block (CB) is described as a complete or partial failure in the propagation of the nervous impulse within the axon. It is diagnostic of focal demyelination, and suggestive of acute demyelinating neuropathies (typically… read more here.
Keywords: demyelinating polyneuropathy; conduction block; case year; year old ... See more keywords
Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
Sign Up to like & getrecommendations! Published in 2020 at "eNeurologicalSci"
DOI: 10.1016/j.ensci.2020.100224
Abstract: Treatment-related fluctuation (TRF), only defined in Guillain-Barre syndrome (GBS), refer to the deterioration of symptoms following treatment-induced improvement, and implies disease activity lasting beyond the effect of immunotherapy. Here, we first propose the concept of… read more here.
Keywords: inflammatory demyelinating; demyelinating polyneuropathy; treatment; subacute inflammatory ... See more keywords
Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies
Sign Up to like & getrecommendations! Published in 2017 at "Neuromuscular Disorders"
DOI: 10.1016/j.nmd.2016.10.008
Abstract: Antibodies to Contactin-1 and Neurofascin 155 (Nfasc155) have recently been associated with subsets of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Contactin-1 and Nfasc155 are cell adhesion molecules that constitute the septate-like junctions observed by… read more here.
Keywords: inflammatory demyelinating; demyelinating polyneuropathy; microscopy; anti nfasc155 ... See more keywords
COVID-19 and MOG-IgG–associated acquired demyelinating polyneuropathy compatible with chronic inflammatory demyelinating polyneuropathy in a previously healthy girl
Sign Up to like & getrecommendations! Published in 2022 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2022.2088466
Abstract: Abstract Neurological manifestations of COVID-19 in the pediatric population are not as well described as those in the adult population. We describe a case of myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)–associated disorder in a 9-year-old… read more here.
Keywords: demyelinating polyneuropathy; mog igg; girl; igg associated ... See more keywords
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
Sign Up to like & getrecommendations! Published in 2022 at "Brain"
DOI: 10.1093/brain/awab422
Abstract: Abstract Intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy usually starts with a 2.0 g/kg induction dose followed by 1.0 g/kg maintenance doses every 3 weeks. No dose-ranging studies with intravenous immunoglobulin maintenance therapy have… read more here.
Keywords: demyelinating polyneuropathy; intravenous immunoglobulin; treatment; inflammatory demyelinating ... See more keywords
Demyelinating polyneuropathy after long‐term treatment with infliximab
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.12642
Abstract: Dear Editor, Tumor necrosis factor (TNF)-a is a proinflammatory cytokine that promotes inflammation within the joints of patients with rheumatoid arthritis (RA). Infliximab, which is a monoclonal antibody to TNF-a, neutralizes the biological activity of… read more here.
Keywords: demyelinating polyneuropathy; long term; infliximab; treatment ... See more keywords
Mechanism and spectrum of anti‐glycolipid antibody‐mediated chronic inflammatory demyelinating polyneuropathy
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Neuroimmunology"
DOI: 10.1111/cen3.12452
Abstract: The pathogenesis of chronic inflammatory demyelinating polyneuropathy (CIDP) is composed of cellular and humoral immunities. Macrophages might play a crucial role in cellular immunity. In addition, autoantibodies participate in the pathogenesis of CIDP. To date,… read more here.
Keywords: inflammatory demyelinating; demyelinating polyneuropathy; lm1; cidp ... See more keywords
Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15553
Abstract: We evaluated the clinical and neurophysiological efficacy of rituximab (RTX) in a neurophysiologically homogeneous group of patients with monoclonal gammopathy and immunoglobulin M (IgM) anti‐myelin‐associated glycoprotein antibody (anti‐MAG) demyelinating polyneuropathy. read more here.
Keywords: demyelinating polyneuropathy; myelin associated; anti myelin; efficacy rituximab ... See more keywords
Differences between acute‐onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the Peripheral Nervous System"
DOI: 10.1111/jns.12266
Abstract: Acute inflammatory demyelinating polyneuropathy (AIDP) and acute‐onset chronic inflammatory demyelinating polyneuropathy (A‐CIDP) are conditions presenting overlapping clinical features during early stages (first 4 weeks), although the latter may progress after 8 weeks. The aim of this… read more here.
Keywords: inflammatory demyelinating; acute inflammatory; demyelinating polyneuropathy; onset chronic ... See more keywords
Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the Peripheral Nervous System"
DOI: 10.1111/jns.12282
Abstract: Intravenous immunoglobulin (IVIG), corticosteroids and therapeutic plasma exchange (TPE) are evidence‐based conventional treatments for chronic inflammatory demyelinating polyneuropathy (CIDP). In many centres, unconventional treatments are frequently used as alternatives. We evaluated the outcome of conventional… read more here.
Keywords: unconventional therapies; inflammatory demyelinating; demyelinating polyneuropathy; chronic inflammatory ... See more keywords